Research and Markets: IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Denmark

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6254fc/ims_pharmaceutical) has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Denmark" report to their offering.

“IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Denmark”

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Key Topics Covered:

HEALTHCARE SYSTEM

• Facts & Figures
• Market Indicators
• Provision & Funding

PRICING

• Prescription Drugs
• Generic Drugs
• Hospital Drugs
• OTC Drugs

REIMBURSEMENT

• Admission to Reimbursement
• Reimbursement Categories
• Reimbursement Prices
• Hospital Reimbursement
• Changes in Reimbursement
• Status Changes in Reimbursement Prices

PHARMACOECONOMICS

• Pharmacoeconomic Requirements
• Price Build Up
• Wholesalers
• Retail Pharmacies
• Dispensing Doctors
• Sales Tax

COST CONTAINMENT

• Industry Paybacks
• Promotional Costs
• Patient Co-payments
• Prescribing Controls
• Generics
• Rx-to-OTC Switches
• Parallel Trade

FUTURE DEVELOPMENTS

• Outlook

NAMES & ADDRESSES

For more information visit http://www.researchandmarkets.com/research/6254fc/ims_pharmaceutical

Source: IMS Health